- Home
- Pathology Industry
- Immunotherapy Market and Forecasts, May 2013
Industries
- Pathology (50)
- Drug and Medication (37)
- Biological Therapy (19)
- Biopharmaceutical (11)
- Diagnostics (8)
-
- Biotechnology (7)
- Genomics (7)
- Blood Supply, Tissue Banking and Transplantation (6)
- Energy & Environment (6)
- Pharmaceutical (4)
- Veterinary Healthcare (3)
- Advanced Material (2)
- Chemical and Material (2)
- Drug Delivery Technology (2)
- Agriculture (1)
- Biomaterial (1)
- Dairy Products and Egg (1)
- Drug Discovery and Development (1)
- Energy (1)
- Generic Drug (1)
Top countries
Publication dates
All regions
data types
- All
- Company Data (599)
- Industry Data
- Country Data (22)
Immunotherapy Market and Forecasts, May 2013
You might be interested in: cancer immunotherapy, cancer, clinical trial, more »
industry reports
Biological Therapy in China : Innovation and Technology Trends
- Industry report
- March 2012
- 15 pages
... March 2012, edhec nice new technologies : dream or reality New technologies immunology: Monoclonal antibodies Radio- immunotherapy Therapeutic vaccines Cytokines Drug ...
- Industries: Biological Therapy
- Countries: China, World
Gene Therapy Sector Overview
- Industry report
- May 2011
- 20 pages
- by Governmental Agency
... Products Cellular therapies Gene therapies Tumor vaccines and immunotherapy Devices used for cells and tissues Human cells and tissues for transplant Combination products 6 octgt ophtho product ...
- Industries: Biological Therapy
Cell Therapy Business in The United States, Belgium and The United Kingdom
- Industry report
- December 2011
- 4 pages
... And immunotherapies (y) workshop leaders: dr alex kudrin, medical director, takeda global research and development, uk dr ronald ellis, senior vice president r&d and chief technology officer, nasvax ltd., Usa dr ...
- Industries: Biological Therapy
- Countries: United States, Belgium, United Kingdom
Biological Therapy Market Trends in The United States and Canada
- Industry report
- February 2013
- 9 pages
... With gvax into a new vaccine named stingvax and has demonstrated superior efficacy over gvax alone in animal models. Combinations are the future of immunotherapy, especially for cancer Said dr. Thomas w ...
- Industries: Biological Therapy
- Countries: United States, Canada
Biological Therapy Market Trends in The United States and Canada
- Industry report
- February 2013
- 9 pages
... With gvax into a new vaccine named stingvax and has demonstrated superior efficacy over gvax alone in animal models. Combinations are the future of immunotherapy, especially for cancer Said dr. Thomas w ...
- Industries: Biological Therapy
- Countries: United States, Canada
Allergy Vaccine Sector Brief
- Industry report
- March 2013
- 15 pages
... Efficacy strong immunogenicity high safety much shorter treatment pharmaceutical quality products strong ip position sit: specific immunotherapy ; ige: immunoglobulin type e ; gmp: good manufacturing ...
- Industries: Drug and Medication
U.S. Pharmaceutical Industry Analysis
- Industry report
- August 2011
- 80 pages
... immunotherapy in melanoma ipimilimab (yervoy) is a monoclonal antibody that blocks a molecule known as cytotoxic t-lymphocyte antigen or ctla-4. Ctla-4 may play a role in slowing down or turning off ...
- Industries: Pathology
- Countries: United States
Allergy Vaccine Sector in The United States, Japan and Finland
- Industry report
- October 2011
- 14 pages
- by Research Paper
... Increased use of immunotherapy in the future seems likely the company mission and objectives the company vision is to extend the use of allergy immunotherapy world-wide, especially by introducing ...
- Industries: Drug and Medication
- Countries: United States, Japan, Finland
U.S. Antibody Industry Brief
- Industry report
- April 2013
- 15 pages
... Present prof. immunotherapy umcu [part-time] 97 00 Vp & scientific director, medarex europe 99 10 Co-founder & cso, genmab 10 Present president & ceo, genmab 2 ...
- Industries: Biopharmaceutical
- Countries: United States
Pharmaceutical : Innovation and Technology Trends
- Industry report
- January 2011
- 18 pages
- by Market Research Publisher
... Indication Deep late stage product portfolio Cancer immunotherapies People Experienced management team Proven ability to execute Product development Fda expertise Licensing and m ...
- Industries: Pathology
Reportlinker.com © Copyright 2013. All rights reserved.
